Asio Capital’s Pfizer PFE Stock Holding History

Asio Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-114,830	Closed	-$2.86M	–	120
2025 Q4	$2.86M	Buy	+114,830	New	+$2.9M	0.4%	72
2020 Q1	–	Sell	-50,421	Closed	-$1.87M	–	149
2019 Q4	$1.87M	Buy	+50,421	New	+$1.8M	0.98%	34

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Asio Capital's PFE Position: Q1 2026 in Review

Asio Capital sold out of Pfizer (PFE) in Q1 2026, closing a stake of 114,830 shares — an estimated $2.86M sold.

Asio Capital first reported a position in PFE in Q4 2019 and held it in 2 quarters. The position peaked at $2.86M in Q4 2025. 2,955 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Asio Capital reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
Asio Capital sold 114,830 Pfizer shares in Q1 2026, an estimated $2.86M.
Asio Capital first reported a position in Pfizer in Q4 2019 and held it in 2 quarters.
Asio Capital's Pfizer position peaked at $2.86M in Q4 2025.
2,955 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Asio Capital's 13F filing for Q1 2026, filed 15 Apr 2026.